Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)

NCT00890929 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
Adult Acute Myeloblastic Leukemia

Interventions

DRUG: Lenalidomide
DRUG: Azacitidine

Sponsor

Stanford University

Collaborators

[object Object]